Chronic hypoxia-induced angiogenesis normalizes blood pressure in spontaneously hypertensive rats

Circulation Research

Volumn 103, Issue 7, 2008, Pages 761-769

  Vilar, José ^a   Waeckel, Ludovic ^a   Bonnin, Philippe ^a   Cochain, Clément ^a   Loinard, Céline ^a   Duriez, Micheline ^a   Silvestre, Jean Sébastien ^a   Lévy, Bernard I ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Angiogenesis; Hypertension; Hypoxia

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART MUSCLE CAPILLARY; HEART OUTPUT; HYPERTENSION; HYPOXIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; QUADRICEPS FEMORIS MUSCLE; RAT; SKELETAL MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; WISTAR KYOTO RAT; ANIMAL; ANOXIA; BLOOD; BLOOD PRESSURE; CHRONIC DISEASE; HEART; PATHOLOGY; PATHOPHYSIOLOGY; TIME; VASCULARIZATION;

ANIMALS; ANOXIA; BLOOD PRESSURE; CARDIAC OUTPUT; CHRONIC DISEASE; HEART; HYPERTENSION; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR RESISTANCE;

EID: 54449088278     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.182758     Document Type: Article

References (38)

1. Feihl F, Liaudet L, Waeber B, Levy BI. Hypertension: a disease of the microcirculation? Hypertension. 2006;48:1012-1017.
2. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104: 735-740.
3. Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens. 2001;14:7-13.
4. Sabri A, Samuel JL, Marotte F, Poitevin P, Rappaport L, Levy BI. Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. Hypertension. 1998;32:371-375.
5. Chen II, Prewitt RL, Dowell RF. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol. 1981;241: H306-H310.
6. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart. 2003;89: 175-178.
7. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99:1873-1879.
8. Lei S, Yong-Yong X, Xiao-Han D, Chang-Sheng C. Geographical differences in blood pressure of male youth aged 17-21 years in China. Blood Press. 2004;13:169-175.
9. Rotta A. Physiologic condition of the heart in the natives of high altitude. Am Heart J. 1947;33:669-676.
10. Ruiz L, Penaloza D. Altitude and hypertension. Mayo Clin Proc. 1977; 52:442-445.
11. Behm R, Honig A, Griethe M, Schmidt M, Schneider P. Sustained suppression of voluntary sodium intake of spontaneously hypertensive rats (SHR) in hypobaric hypoxia. Biomed Biochim Acta. 1984;43: 975-985.
12. Barbarash NA, Dvurechenskaia G, Volina EV, Berdysheva LV, Putintseva TG. [Effect of adaptation to the altitude hypoxia on catechol-amine metabolism in rats with spontaneous hereditary hypertension]. Biull Eksp Biol Med. 1982;93:22-24.
13. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660.
14. Blanes MG, Oubaha M, Rautureau Y, Gratton JP. Phosphorylation of tyrosine 801 of the VEGFR-2 is necessary for AKT-dependent eNOS activation and nitric oxide release from endothelial cells. J Biol Chem. 2007;282:10660-10669.
15. Krege JH, Hodgin JB, Hagaman JR, Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995;25:1111-1115.
16. Baker HJ, Lindsey JR, Weisbroth SH. Biology and diseases. In: Baker HJ, Lindsey JR, Weisbroth SH, eds. The Laboratory Rat. New York: Academic Press; 1979, 59-74.
17. Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A, Levy BI. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ Res. 2001; 89:259-264.
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
19. Janssens SP, Thompson BT, Spence CR, Hales CA. Functional and structural changes with hypoxia in pulmonary circulation of spontaneously hypertensive rats. J Appl Physiol. 1994;77:1101-1107.
20. Henley WN, Tucker A. Hypoxic moderation of systemic hypertension in the spontaneously hypertensive rat. Am J Physiol. 1987;252: R554-R561.
21. Mifflin S. New insights into the electrophysiology of brainstem circuits controlling blood pressure. Curr Hypertens Rep. 2007;9:236-241.
22. Hainsworth R, Drinkhill MJ, Rivera-Chira M. The autonomic nervous system at high altitude. Clin Auton Res. 2007;17:13-19.
23. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcircu-lation in young patients with high-output borderline hypertension. Hypertension. 1983;5:844-851.
24. Gasser P, Buhler FR. Nailfold microcirculation in normotensive and essential hypertensive subjects, as assessed by video-microscopy. J Hypertens. 1992;10:83-86.
25. Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibirica E. Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens. 2006;19:477-483.
26. Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol Med Today. 1998;4:122-129.
27. Berra E, Ginouves A, Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 2006; 7:41-45.
28. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest. 1996;97:469-476. (Pubitemid 26039412)
29. Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A. 1998;95:15809-15814.
30. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest. 1995;95:1798-1807.
31. Waltenberger J, Mayr U, Pentz S, Hombach V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation. 1996;94:1647-1654.
32. Wang H, Olszewski B, Rosebury W, Wang D, Robertson A, Keiser JA. Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression. Biochem Biophys Res Commun. 2004;315: 363-368.
33. Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI. Proan-giogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res. 2001;89:678-683.
34. Silvestre JS, Kamsu-Kom N, Clergue M, Duriez M, Levy BI. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. J Pharmacol Exp Ther. 2002;303:1038-1043.
35. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, flu-orouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
36. Mourad JJ, des Guetz G, Debbabi H, Levy BI. Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann Oncol. 2008;19:927-934.
37. Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, Zioncheck TF, Holmgren EB, McCluskey ER. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am Heart J. 2001;142:872-880.
38. Yang R, Ogasawara AK, Zioncheck TF, Ren Z, He GW, DeGuzman GG, Pelletier N, Shen BQ, Bunting S, Jin H. Exaggerated hypotensive effect of vascular endothelial growth factor in spontaneously hypertensive rats. Hypertension. 2002;39:815-820.